BHG - Bright Health soars 12% after guiding FY2022 revenue of $6.5B above consensus

December, 07 2021 06:57 AM Bright Health Group Inc.

Bright Health Group (NYSE:BHG) reaffirms 2021 guidance of $4.1B to $4.2B in Revenue (consensus $4.13B) and introduced 2022 guidance that includes significant growth across both NeueHealth and Bright HealthCare businesses. Shares up 12.4% premarket at $4.25. For 2022, BHG expects Enterprise Revenue in the range of $6.3B to $6.5B (consensus $5.89B). Enterprise Medical Cost Ratio is expected to be between 86.0% - 88.0%. Adjusted EBITDA loss is projected between $500M to $400M. The Bright HealthCare segment is expected to begin the year with approx. 900,000 members as a result of strong AEP/OEP enrollment. The NeueHealth segment is expecting ~$2B in Revenue, with approx. one-third coming from external sources.

For further details see:

Bright Health soars 12% after guiding FY2022 revenue of $6.5B above consensus

Company Name:	Bright Health Group Inc.
Stock Symbol:	BHG
Market:	NYSE

Twitter